chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had large dark bruise day after injection and pain for 3 days. Much swelling of upper arm and upper area of shoulder and arm pit area started 6 days after injection and continued until doctor told me to put ice packs for 20 minutes 4x day on area. Today is 2/02 and arm =still swollen but not as swollen as it was before icing. Tried to keep arm elevated when sitting.
Pt states he had temporary hearing loss left ear and a flair up of his Uveitis the day after receiving the vaccine.
APPROXIMATELY 10 MINUTES AFTER RECEIVING VACCINATION THE PATIENT FELT LIGHT HEADED AND PASSED OUT-HE WAS OUT ABOUT 5-6 SECONDS--WE RESPONDED AS HE CAME TO--HE WAS DISORIENTED --WE CALLED AN AMBULANCE--IN  ABOUT 10-15 SECONDS HE WAS FULLY ALERT AND DID NOT WANT THE AMBULANCE WHICH WE CANCELED--HE STARTED SWEATING PROFUSELY AND WE HAD HIM REST ON THE FLOOR--WE GAVE HIM A BOTTLE OF WATER WHICH HE DRANK AND IN  ABOUT 5 MINUTES HE FELT COMPLETELY BETTER--WE HAD HIM SIT IN A CHAIR FOR A FEW MINUTES THEN HE GOT UP WALKED  AND SAID HE WAS COMPLETELY FINE. IT SHOULD BE NOTED THAT HE HAD A DREAD FEAR OF NEEDLES. WE ARE NOT SURE IF THIS PLAYED ANY ROLE IN THIS REACTION
Patient presented to mobile vaccine clinic with Covid card and ID, No indication of booster dose noted on card.  Primary Series documented completed on 8/26/21 and 11/5/21.  Patient indicated he was there for "Booster #1".  Given booster by Nurse, documented as Booster #1.  Upon entering information into agency, found that patient had Booster #1 on 4/22/22 at pharmacy.
suspected vaccination failure; had shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported for the reporter's sister in law. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. Reporter also had shingles and asked doctor if he could guarantee that he/she would not get them again and he said no. Reporter stated that, there was not been any studies on it to make a guarantee. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Patient started with leg swelling the night of vaccines. Seen at clinic on 8/3/22 due to worsening swelling and redness, blister about the size of a quarter on thigh at this point. Pt was treated with cephalexin and sulfamethoxazole to cover for MRSA/strep/staph. Pt admitted to hospital on 8/4/22 due to worsening cellulitis and treated with IV Clindamycin, rapid improvement while on IV antibiotics.
feeling very unwell for a short period of time; This case was reported by a other health professional via call center representative and described the occurrence of malaise in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of malaise (received 1st dose on an unknown date, refer case US2020AMR037675).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced malaise. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the malaise was recovered/resolved.   It was unknown if the reporter considered the malaise to be related to Shingrix.  Additional information was received as follows: The age at vaccination was not reported. The patient received 2nd dose Shingrix and experienced feeling very unwell for a short period of time. As per the reporter, she normally did not experienced any untoward event following receipt of vaccines. The reporter declined consent for follow up.
Within 5 days patient was having pain on side/back. Went to MD 1 wk after immunization and was diagnosed with shingles.
25APR96 t105:alternate APAP & Ibuprofen, sponge off, push fluids;26APR96 t104 all noc, starlets easily, temp now 100;27APR96 t100-101, screams a lot, startles;stop APAP use Ibuprofen;no more pertussis
Pain to the injection; can't lift or use my arm; headache; This is a spontaneous report from contactable consumer. A 43-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Formulation: Solution for injection) (Lot Number: EL3247, Expiry date: May2021), via unspecified route of administration on unspecified date as single dose for COVID-19 Immunization. Patient medical history and concomitant medication were not reported. Patient experienced pain to the injection site, can not lift or use my arm and headache. She stated that no fever at this time. Was fine after getting the shot yesterday and by the evening my arm started to really hurt and now in the morning it was worse with a headache on unspecified date. Treatment received to event she took Tylenol. Outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
Missed 2nd dose in recommended time frame; Slight cough/senses for 2 days after possible exposure to covid; close proximity of people infected with covid and may have been exposed to the virus; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose in recommended time frame), COUGH (Slight cough/senses for 2 days after possible exposure to covid) and EXPOSURE TO SARS-COV-2 (close proximity of people infected with covid and may have been exposed to the virus) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose in recommended time frame), COUGH (Slight cough/senses for 2 days after possible exposure to covid) and EXPOSURE TO SARS-COV-2 (close proximity of people infected with covid and may have been exposed to the virus). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose in recommended time frame) had resolved and COUGH (Slight cough/senses for 2 days after possible exposure to covid) and EXPOSURE TO SARS-COV-2 (close proximity of people infected with covid and may have been exposed to the virus) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
21NOV97 AM hives face, chest, back;to ER on 22NOV AM w/swollen face, hands, feet & given unk med;resolving on 24NOV;to MD who suggested titer prior to 3rd inj;mom denied any change in diet, soaps, or med prior to hive onset;
EXTRACTING MORE THAN 5 DOSES; OFF LABEL USE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number is not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced extracting more than 5 doses, and off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the extracting more than 5 doses and off label use was not reported. This report was non-serious.
consistent fatigue, abdominal pain, diarrhea, muscle aches, chills, gas/bloating.  Currently on Day 3 of reactions and seems to be subsiding.  Took over the counter anti-gas, anti diarrhea and stomach remedies.
glands in throat to swell/It feels like i have a golf ball in my throat; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (glands in throat to swell/It feels like i have a golf ball in my throat) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (glands in throat to swell/It feels like i have a golf ball in my throat). At the time of the report, LYMPHADENOPATHY (glands in throat to swell/It feels like i have a golf ball in my throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.   Reporter did not allow further contact
Itches; Rash on right shoulder; A spontaneous report was received from a (Consumer) concerning a  89Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events (PT term) list.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On17JAN2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 028LZON ) intramuscularly in the Anatomical location for prophylaxis of COVID-19 infection.  On17JAN2021, The patient experienced the events list (verbatims) with seriousness criteria. Moderna Customer Care. Case Number 00030215 Patient reaceived the first dose of the Moderna Covid-19 vaccine on the 17JAN2021 on her left and yesterday, she noticed rash on right shoulder and it itches.On the first day after receiving the vaccine, she took ibuprofen and 4 hours later she took it again. Patient is an 89 year old female. She takes vitamins, Prevagen, Losartan, Amlodipine. She received the vaccine at a Pharmacy. Lot number 028LZON Consent was received for safety to follow-up and for this call to be documented. She wants to know when she will receive her second dose and How will she find out about it. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  unknown outcomes: At the time of this report, the outcome of the event(s) (when there are multiple events, list out which events are being referenced here) was unknown>.
Patient with 2 COVID vaccinations who admitted to hospital with positive COVID test.  Some GI issues, not hypoxic.  Provdier d/c note:  "32-year-old male with history of DM 1 with insulin pump/sensor with right BKA who was advised to come back to hospital for GPC bacteremia for which patient was monitored and blood culture grew micrococcus which ID assessed as being a contaminant.  However during hospitalization patient developed DKA secondary to malfunctioning insulin pump which resolved after insulin pump placed back on patient correctly.  Patient with poor appetite during this hospitalization secondary to COVID as well as history of gastroparesis but patient feels that he is safe for discharge home and that he should be able to eat well upon discharge to home.  Patient discharged to home."
patient stated started with body ache at 6pm night of injection. woke up at 10am with general itch and self reported hives. Patient states cerave cream is working fine at helping with itch
I feel dizzy today.  I received my vaccine on mid afternoon on Friday, with very symptoms (except a sore arm).  When I got out of bed this morning, I couldn't walk a straight line.   My head feels heavy.
Body aches and chills with swelling, redness, pain and warmth to administration site.
Patient was administered a second dose of Moderna Bivalent covid-19 vaccine. Standing orders from the state have not been issued hence the need for this to be reported as it was given out of the recommendations by the state.  No adverse reactions noted during the observation period.
It was reported that a female patient received a Fluzone Unspecified '99-00 vaccination on 10/28.99. Reportedly that same day, the patient developed an irregular heartbeat. The patient reports that she is 'still undergoing tests by the doctor". From additional information received 12/23/99, it was confirmed that the patient received a Fluzone  SV '99 -00 vaccination on 10/28/00. Within half a hour of the vaccination, the patient developed shortness of breath, chest heaviness and nausea. The patient was seen in the emergency room and follow-up was done by a cardiologist. From additional information received on 01/17/00, additional patient responsible physician and laboratory work information was provided. From additional correspondence received on 01/17/00, additional patient, responsible physician and laboratory work information was provided. From additional correspondence received on 01/24/00, it was reported that the patient also experienced, "choking of the throat feeling", PVC's dizziness, almost and/or momentary blacking out and fainting  feeling, blurry vision, physical exhaustion  and temperature of 98.9 to 100.5 deg F. The patient also experienced some memory hardships with speech difficulties to relay thoughts. These episode occurred right after the shot and continue daily, along with periods of irregular (heart) beats.  The patients also experienced three episodes of sudden shaking and chills with a temperature of 96.5 to 97 deg F which occurred only days after the vaccination. Follow-up #1 (8/08/02: During internal auditing of all files, it was deemed necessary to amend the report by updating the Adverse Event coding (added Larynismus, and deleted Convulsions). Also reranked adverse events.
Arm soreness; fatigue; This is a spontaneous report from a contactable consumer.   A 23-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose at right arm on 18Dec2020 08:00 for immunization, administered at hospital.  The patient medical history was not reported. No known allergies. Concomitant medication included MultiVitamins and colecalciferol (VITAMIN D [COLECALCIFEROL]). The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced arm soreness and fatigue on 18Dec2020 11:00. The patient has received not treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The action taken in response to the events for bnt162b2 was not applicable. The outcome of events was recovering.  Information on the lot/batch number has been requested.
pt had slight rash extending from vax site down to elbow, both arms also had rash on thighs.
Information has been received from an office manager at a physician's office concerning a 27 year old female medical assistant who on 12-DEC-2007 was administering a dose of prefilled Gardasil (Lot #1287U) and the safety device on the syringe did not fully activate and the needle did not pull back into the cylinder. After the dose was administered, when the medical assistant reached for the syringe to remove the lot number label to put it into the patients records, she accidentally pricked her right index finger. The syringe and packaging did not appear to be damaged. The syringe was sealed in it's package when received. She immediately cleaned her finger. She, and the patient who received the Gardasil vaccine, were both given blood tests at the hospital to screen for HIV and Hepatitis. The results of the blood tests were not available at the time of reporting. The medical assistant reported that her finger was tender. Additional information has been requested. A follow up was received and the first results of the HEP B and HEP C for the patient who received the Gardasil vaccine and the medical assistant were negative. The HIV test results were negative as well. Physician's office wants to retest both in 6 months to be certain of no disease. This is one of several reports with the same source.
None at the time, but with in 3 weeks, I had developed extremely high, uncontrolled blood pressure.
Received IM FLUZONE vaccine by pharmacist. Vaccine on 12/13/2012. Immediately noticed pain radiating down arm and in lower back. Noted fasciculations Feb 10 2013. Seen by MD Feb 11 2013 for this symptom. Seen Feb 18 2013 by neurology for EMG for fasciculations. Insomnia began in Feb 2013. Seen May at clinic for EMG- fasciculations. Found to have positive voltage gated potassium channel antibodies. Sleep study clinic Oct 2014- no stage 3 or 4 sleep, severe insomnia. MRI sleep/ neurology 11/14 shows FLAIR white scatter spots. Neurologist states condition is likely immune response.
Moderna COVID-19 Vaccine EUA shot received with no symptoms after first shot.  Second shot, experienced fatigue, confusion and chills about 5 hours after vaccine. Days 1-2 after experienced heavy congestion, fatigue, dry cough, fatigue, headache, confusion, feverish tendencies. 3 days after woke with no smell and limited taste, dry cough and congestion continued. Called nurse hotline who recommended I take covid PCR test. Tested negative. 4 days after shot continue to experience dry cough, mild headache, brain fog, loss of smell/taste.
I had the first COVID vaccine on January 28, the second on Feb. 25, then on April 13 I spent most of a day in the hospital E.R.  with the ultimate diagnosis of an 8 inch long DVT in the left and multiple blood clots throughout both lungs.  Now the CDC suggests getting a booster.  I am afraid to on the chance that it might result in pulmonary emboli that kill me this time.  I would appreciate your take on this.
Pt took pill # 2 at 10am 2-3-2020, by the next night at 9pm she was feverish, achy, and had emesis. Felt ill X24 hours. Did not got to the doctor, stayed home and hydrated and slept. Does not remember when she took pill # 3, which was due to be taken at 10am 2-5-2020, all she knows is that by the time she spoke with this writer on Thursday 2-6-2020 at 1pm it was not in the package. She feels she must have taken it as scheduled but she really does not remember taking it. By this time she was feeling much better, no fever and keeping food down, so took pill #4 as planned at 10am 2-7-2020. She then reported to this writer on Monday 2-10-2020 that she developed a rash all over her body.
Extreme dizziness. 1st 3 days falling down and banging into things. I am still having a lot of dizziness and needing to grab into things 22 days later. I do vertigo exercises that aren?t really helping. I take dramamine 3 times a day and it does ease dizziness. I just want to know how long air will have to take this and when it will get better? I?m told this is a normal side effect but for how long? It is very bad at end of day and when I?m tired. The room spins horribly. I throw up from dizziness as well.
ringing in the ear; pain on the knee; This is a spontaneous report from a contactable consumer or other non hcp.  A male patient of an unspecified age received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported) via an unspecified route of administration on  an unspecified date dose unknown, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient experienced ringing in the ear and pain on the knee on an unspecified date. The event outcome was reported as unknown  No follow-up attempts are possible: Information about lot/batch number cannot be obtained.
Extreme pain in shoulder of vaccinated arm, followed by frozen shoulder and continuing pain. Treatment included resting arm, hot and cold compresses and massage, followed by three sessions of physical therapy beginning on 02/25/2016 and ending 06/04/2016.
Red urine; This spontaneous case was reported by a physician and describes the occurrence of CHROMATURIA (Red urine) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced CHROMATURIA (Red urine). At the time of the report, CHROMATURIA (Red urine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment medications were not reported  no concomitant medications were reported
Muscle pain in shoulder and lower neck on left side.; Muscle pain in shoulder and lower neck on left side.; Muscle pain in shoulder and lower neck on left side.; This is a spontaneous report from a contactable consumer (patient herself). A 57-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration in left arm on 13Mar2021 13:45 as single dose for COVID-19 immunization. Medical history included Post-concussion syndrome and crainiotomy. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), trazodone, levothyroxine sodium (LEVOXYL), sertraline hydrochloride (ZOLOFT), cefixime (FLEXERIL) and the patient received another unspecified medication. Patient previously took Ciprofloxacin and experienced with allergy. On 13Mar2021 14:00 patient stated that she was experienced with Muscle pain in shoulder and lower neck on left side. Patient received treatment was reported as no. Outcome of events was not recovered.  Information on the lot/ batch number has been requested.